LLY: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/37ed6849-6273-4437-8dba-5acaf06e1a73/","filing_uuid":"37ed6849-6273-4437-8dba-5acaf06e1a73","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/37ed6849-6273-4437-8dba-5acaf06e1a73/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Cristina Antelo","dt_posted":"2026-07-20T13:54:37-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"309 Pennsylvania Avenue SE","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":401104769,"url":"https://lda.gov/api/v1/registrants/401104769/","house_registrant_id":null,"name":"FEROX STRATEGIES","description":"Government relations.","address_1":"309 Pennsylvania Avenue SE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CRISTINA ANTELO","contact_telephone":"+1 202-320-8236","dt_updated":"2026-07-30T18:00:40.247718-04:00"},"client":{"id":208957,"url":"https://lda.gov/api/v1/clients/208957/","client_id":202,"name":"ELI LILLY AND COMPANY","general_description":"American pharmaceutical company.","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-03-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to the pharmaceutical industry. Issues related to treating and reducing obesity. Issues related to drug shortages and counterfeit products.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67961,"prefix":null,"prefix_display":null,"first_name":"CRISTINA","nickname":null,"middle_name":null,"last_name":"ANTELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71787,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":93773,"prefix":null,"prefix_display":null,"first_name":"DEBRA","nickname":null,"middle_name":null,"last_name":"DIXON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146075,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TAGGART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152876,"prefix":"mr","prefix_display":"MR.","first_name":"ZACHARY","nickname":null,"middle_name":"BENJAMIN","last_name":"FRIEND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}